ClinicalTrials.gg
CompletedNCT07000929Updated Nov 2, 2026

Videonystagmography and Vestibular Migraine

An observational study in Migraine Disorders and Vertigo, sponsored by Dr. med. Lukas Becker. Completed at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Dr. med. Lukas Becker · Observational

Study type
Observational
Model
Case-control
Time perspective
Other
Enrollment
175
Ages
18 Years and older
Sex
All
01

Study summary

In the study, the investigators would like to examine whether there is a difference between patients with vestibular migraine, patients with episodic or chronic migraine and healthy subjects in the examination of videonystagmography, which has been used for many years to differentiate and diagnose vertigo disorders. Accordingly, videonystagmography could also be discussed as an important diagnostic instrument for the diagnosis of the still young disease vestibular migraine.

Read the detailed description

Vestibular migraine is a young disorder that is caught between headache experts and vertigo experts. In 2012, the International Bárány Society for Neurootology and the International Headache Society were able to agree on a uniform definition and terminology for "vestibular migraine" in a jointly formulated consensus paper. A distinction is currently made between "definite" and "probable" vestibular migraine on the basis of the applicable diagnostic criteria. The diagnostic criteria are based on a study from 2001 with 75 patients and a follow-up period of 8 years, in which the diagnosis was confirmed in 84% of cases. At present the diagnostic criterion still requires the exclusion of another possible vestibular or ICHD diagnosis. Vestibular migraine is reported in the literature as the most common cause of spontaneous episodic vertigo attacks in adults and children. A manifestation is basically possible at any age. Despite the frequency of vestibular migraine and the sometimes pronounced level of suffering, the publication density is low and the diagnosis is mainly based on the patient medical history and clinical neurological examination. No specific instrumental diagnostic method or specific biomarkers that confirm or even prove the diagnosis are known. Larger studies with the intention of improving the diagnosis and thus achieving the expected reduction in the postulated high number of unreported cases have not yet been carried out. In the regular examination of patients with vertigo, videonystagmography with caloric testing is already an established and necessary examination procedure that is used to diagnose many different vertigo disorders. In the investigations, patients with confirmed vestibular migraine often show a vestibular hyperexcitability or increased caloric reaction not previously described in the literature. The investigators would like to verify this with this study. The investigators therefore developed the hypothesis of a possible correlation between a certain nystagmus frequency and/or certain speed of the slow phase of the nystagmus and the presence of a vestibular migraine. Comparisons with patients with headache migraine without accompanying vertigo symptoms and with a healthy control group should be carried out to test the hypothesis. First, all patients at the Dizziness Center at University Hospital Essen with diagnosed vestibular migraine without other conditions, except episodic or chronic migraine, were analyzed in the first quarter of 2023. This was followed by the inclusion of patients with episodic or chronic migraine and no vestibular migraine, standardized by age and gender, as well as the inclusion of a healthy control group without migraine headache and without vestibular migraine. Following that the collected data will be analyzed in particular the videonystagmography with caloric testing and the comparison of the groups.

02

Conditions studied

  • Migraine Disorders
  • Vertigo

Keywords

  • Vestibular migraine
  • Vertigo
  • Migraine
  • Dizziness
03

In context

Migraine Disorders

1,657 studies on the registry are indexed under Migraine Disorders; 339 are open to participants now.

This study's enrollment of 175 is above the median of 137 across 331 observational studies indexed under Migraine Disorders.

Browse Migraine Disorders studies →

Lead sponsor

This is the only study on the registry with Dr. med. Lukas Becker as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The sample of patients was recruited from the dizziness center of the University Hospital Essen. The patients with migraine were recruited partly from the headache center and partly via advertising. The healthy subjects were recruited through advertising.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Group 1: The diagnosis of vestibular migraine is confirmed.
  • Group 2: The diagnosis of episodic or chronic migraine is confirmed. There is no coexisting vestibular migraine.
  • Group 3: healthy subjects without vestibular migraine and episodic or chronic migraine

Exclusion criteria

Exclusion Criteria:

  • Simultaneous presence of another confirmed vertigo disorder
  • A previous hearing loss
  • Simultaneous presence of a chronic disease that affects the sense of balance
  • Taking medication with a central effect that affects the sense of balance
  • An existing eardrum defect or a blocked ear canal due to earwax
05

Study design

Observational model
Case-control
Time perspective
Other
Enrollment
175 participants (actual)
Patient registry
No

Groups and cohorts

  • Vestibular migraine confirmed

    Patients who received a diagnosis of vestibular migraine. Patients were included in the study retrospectively.

    Diagnostic Test: Videonystagmography

  • Episodic or chronic migraine, without vestibular migraine

    Participants who received a diagnosis of episodic or chronic migraine without vestibular migraine. Participants were included in the study prospectively.

    Diagnostic Test: Videonystagmography

  • Healthy participants

    Participants who not received a diagnosis of episodic or chronic migraine nor vestibular migraine. Participants were included in the study prospectively.

    Diagnostic Test: Videonystagmography

Interventions

  • Diagnostic testVideonystagmography

    In the regular examination of patients with vertigo, videonystagmography with thermal testing (caloric) is already an established and necessary examination procedure that is used to diagnose many different vertigo disorders.

06

What researchers measure

Primary outcomes

  1. mean comparison nystagmus frequency

    Comparison of the mean between the group of patients with vestibular migraine and the patients and healthy participants in the mean nystagmus frequency within 30 seconds

    Time frame: Mean of nystagmus frequency at study enrollment, Baseline

  2. mean comparison GLP (speed of the slow phase) of nystagmus in °/s or sum of °/s

    Comparison of the mean between the group of patients with vestibular migraine and the patients and healthy participants in the mean GLP of nystagmus in °/s or sum of °/s

    Time frame: Mean of nystagmus GLP at study enrollment, Baseline

  3. Comparison head impulse test (vHIT)

    Comparison of the mean between the group of patients with vestibular migraine and the patients and healthy participants in the qualitativ analysis of the head impulse test

    Time frame: result of head impulse test at study enrollment, Baseline

07

Study locations

1 site
  • Westdeutsches Kopfschmerz und Schwindelzentrum der Klinik für Neurologie des Universitätklinikums Essen
    Essen, North Rhine-Westphalia 45147, Germany
08

References and documents

Publications

  • Rocha MF, Sacks B, Al-Lamki A, Koohi N, Kaski D. Acute vestibular migraine: a ghost diagnosis in patients with acute vertigo. J Neurol. 2023 Dec;270(12):6155-6158. doi: 10.1007/s00415-023-11930-9. Epub 2023 Aug 19. No abstract available. PubMed 37597072 ↗
  • Muelleman T, Shew M, Subbarayan R, Shum A, Sykes K, Staecker H, Lin J. Epidemiology of Dizzy Patient Population in a Neurotology Clinic and Predictors of Peripheral Etiology. Otol Neurotol. 2017 Jul;38(6):870-875. doi: 10.1097/MAO.0000000000001429. PubMed 28498271 ↗
  • Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, Bisdorff A, Versino M, Evers S, Newman-Toker D. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22(4):167-72. doi: 10.3233/VES-2012-0453. PubMed 23142830 ↗

Individual participant data

Plan to share: No — Disclosure of personal hospital data was not agreed in the ethics vote. The patient was informed with the indication that the data would not be passed on.

09

Updates

1 registry update since Sep 25, 2026
Minor edits
Nothing that changes what the study is or who can join. Edited: design details and arm descriptions
1 update, last Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    Minor edits only
    + 2 other changes: design details and arm descriptions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07000929
Lead sponsor
Dr. med. Lukas Becker
Responsible party
Dr. med. Lukas Becker (Principal Investigator, Universitätsklinikum Essen) — Sponsor-investigator
First posted
Jun 3, 2025
Start date
Oct 16, 2023
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025
Last update
Nov 2, 2026

Study contacts

Dagny Holle-Lee, Prof. Dr. med.
study director · Klinik für Neurologie, Universitätsklinikum Essen

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion